Clinical trial · Interventional
Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A trial will be conducted on 200 breast cancer patients with adjuvant hormonal therapy. The study included 6 months baseline measurement, and 12 months intervention. Patients will be assigned to high adherence or low adherence group. Then, through randomization, low adherence patients will be assigned to the intervention or control group. Study Coordinator delivers the intervention using the WALKON mobile application. Control participants receive usual care with continuous monitoring using Medication Event Monitoring System (MEMS) device.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| low adherence intervention group | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- NO_INTERVENTION
- label
- high adherence control group
- description
- -Patients on continuous MEMS monitoring with usual care.
- type
- NO_INTERVENTION
- label
- low adherence control group
- description
- -Patients on continuous MEMS monitoring with usual care.
- type
- EXPERIMENTAL
- label
- low adherence intervention group
- description
- * Patient with the WALKON mobile application. * Patient with monthly feedback call * Patients on continuous MEMS monitoring.
- interventionNames
- Behavioral: low adherence intervention group
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Stage 0-III breast cancer * Treated with Adjuvant hormonal therapy Exclusion Criteria: * Stage IV breast cancer * Breast cancer recurrence or metastasis * Severe medical illness
References
Publications (0)
Data not yet available